Novel drug could eliminate hepatitis C in 15 years Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination with other drugs.…
Chief medical officer’s annual report focuses on mental healthCMO Sally Davies has called for an end to healthcare providers’ focus on “wellbeing”, saying there is little evidence to support this approach for tackling mental ill-health.…
Potential role for benralizumab in COPD patients with eosinophilia Benralizumab therapy led to a numerical, albeit not statistically significant, improvement in COPD exacerbations and lung function compared with placebo.…
World Health Organization expedites trials for potential Ebola vaccines The World Health Organization has announced that two vaccines will be expedited to clinical trials and could be available as soon as November 2014 for priority use in healthcare workers.…
How pharmacists can improve the care of vulnerable patients Specialist pharmacists discuss the issues surrounding vulnerable patient groups at the RPS annual conference.…
BioCryst remains hopeful of FDA approval for its single-dose influenza drug despite mixed results An experimental single-dose influenza drug has demonstrated mixed results in treating adult patients with flu when administered within 48 hours of the onset of symptoms.…
Efforts to counter climate change-related health risks need to be put centre stage, says WHO President of the World Bank Group Jim Yong Kim calls for action on climate change, saying most serious impacts will be on public health.…
World’s most expensive drug gets green light from NICE The National Institute for Health and Care Excellence has paved the way for making the most expensive drug in the world available on the NHS.…
Self-management effective for people with hypertension A new study shows that people who manage their own hypertension appear to have better control of the condition.…
Novel heart failure therapy shows “overwhelming benefit”, trial shows A novel treatment for heart failure could save the lives of 20% more patients than the current gold-standard therapy.…